Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,689
Total Claims
$885K
Drug Cost
704
Beneficiaries
$1,257
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+7%
Cost per patient vs peers
$1,257 vs $1,174 avg
-3%
Brand preference vs peers
8.6% vs 8.9% avg
Brand vs Generic
Brand: 1,087 claims · $658K
Generic: 11,511 claims · $221K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 164 | $129K |
| Tirzepatide | 87 | $118K |
| Sitagliptin Phosphate | 39 | $32K |
| Dapagliflozin Propanediol | 31 | $28K |
| Insulin Aspart | 37 | $27K |
| Semaglutide | 22 | $26K |
| Rivaroxaban | 20 | $25K |
| Evolocumab | 23 | $24K |
| Empagliflozin | 19 | $24K |
| Linaclotide | 24 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 31 | $17K |
| Fluticasone/Umeclidin/Vilanter | 22 | $15K |
| Insulin Lispro | 19 | $13K |
| Fluticasone Propion/Salmeterol | 45 | $12K |
| Mirabegron | 14 | $11K |
Prescribing Profile
Patient Profile
72
Avg Age
58%
Female
1.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data